首页 › 基金 › TANAKA CAPITAL MANAGEMENT INC › NUVB
TANAKA CAPITAL MANAGEMENT INC 对 NUVB 的持仓历史
NUVATION BIO INC · 医疗保健
TANAKA CAPITAL MANAGEMENT INC 在 Q1 2026 的 13F 申报中披露持有 NUVB(NUVATION BIO INC)901,825 股,市值约 US$3.9M,约占其申报组合的 6.46%,在其申报持仓中市值排名第 6 位。 TANAKA CAPITAL MANAGEMENT INC 最近 3 个申报季度中有 3 个季度披露了 NUVB 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
TANAKA CAPITAL MANAGEMENT INC 对 NUVB 的持仓演变
TANAKA CAPITAL MANAGEMENT INC 于 Q3 2025 首次披露 NUVB 持仓:685,105 股(约 US$2.5M)。 该持仓在 Q4 2025 达到峰值 841,605 股,市值约 US$7.5M。 在 3 次申报中,TANAKA CAPITAL MANAGEMENT INC 2 次增持、0 次减持、0 次保持不变。 最近一期申报(Q1 2026)显示持股 901,825 股、市值约 US$3.9M,环比增持 60,220 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 685.11K | $2.54M | 新进 |
| Q4 2025 | 841.61K | $7.54M | 增持 |
| Q1 2026 | 901.83K | $3.87M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NUVB 与 13F 数据
NUVB(NUVATION BIO INC)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 NUVB,申报仓位最大的包括:Decheng Capital LLC (US$147.4M), Omega Fund Management, LLC (US$45.9M), Laurion Capital Management LP (US$44.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NUVB 的基金
- Decheng Capital LLC 25.95M 股 · $147.42M · Q2 2026
- Omega Fund Management, LLC 8.08M 股 · $45.90M · Q2 2026
- Laurion Capital Management LP 7.82M 股 · $44.42M · Q2 2026
- Context Capital Management, LLC 30.00M 股 · $31.29M · Q2 2026
- Polar Asset Management Partners Inc. 25.00M 股 · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M 股 · $25.79M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M 股 · $18.74M · Q2 2026
- Redmile Group, LLC 3.03M 股 · $17.22M · Q2 2026
- Knoll Capital Management, LLC 1.60M 股 · $9.08M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M 股 · $7.53M · Q3 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M 股 · $7.22M · Q2 2026
更多关于 TANAKA CAPITAL MANAGEMENT INC
常见问题
How long has TANAKA CAPITAL MANAGEMENT INC held NUVB?
TANAKA CAPITAL MANAGEMENT INC has disclosed NUVB holdings in 3 of the last 3 reported quarters, going back to Q3 2025.
What is TANAKA CAPITAL MANAGEMENT INC's current position in NUVB?
As of Q1 2026, TANAKA CAPITAL MANAGEMENT INC holds 901.83K shares of NUVB (NUVATION BIO INC), valued at $3.87M, representing 6.46% of its reported portfolio and ranking #6.
Has TANAKA CAPITAL MANAGEMENT INC been buying or selling NUVB?
In the latest 13F filing (Q1 2026), TANAKA CAPITAL MANAGEMENT INC increased its position in NUVB. The position peaked in Q4 2025 at 841.61K shares.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Omega Fund Management, LLC, Laurion Capital Management LP, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.